These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7549040)

  • 1. Antitumor effect of keto-diepoxides isolated from the fungus Nattrassia mangiferae.
    King I; Blood C; Chu M; Patel M; Liu M; Li Z; Robertson N; Maxwell E; Catino JJ
    Oncol Res; 1995; 7(1):1-5. PubMed ID: 7549040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice.
    Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Li Z; Dell J; Lipari P; Malkowski M; Prioli N; Rossman RR; Korfmacher WA; Nomeir AA; Lin CC; Mallams AK; Doll RJ; Catino JJ; Girijavallabhan VM; Kirschmeier P; Bishop WR
    Cancer Chemother Pharmacol; 1999; 43(1):50-8. PubMed ID: 9923541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel ketoepoxides block phospholipase D activation and tumor cell invasion.
    Pai JK; Frank EA; Blood C; Chu M
    Anticancer Drug Des; 1994 Aug; 9(4):363-72. PubMed ID: 7916902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice.
    Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Lipari P; Malkowski M; Ferrari E; Nielsen L; Prioli N; Dell J; Sinha D; Syed J; Korfmacher WA; Nomeir AA; Lin CC; Wang L; Taveras AG; Doll RJ; Njoroge FG; Mallams AK; Remiszewski S; Catino JJ; Girijavallabhan VM; Bishop WR
    Cancer Res; 1998 Nov; 58(21):4947-56. PubMed ID: 9810004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
    Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
    Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
    Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
    Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor activity of mycophenolate mofetil against human and mouse tumors in vivo.
    Tressler RJ; Garvin LJ; Slate DL
    Int J Cancer; 1994 May; 57(4):568-73. PubMed ID: 8181860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new angiogenesis inhibitor, FR-111142.
    Otsuka T; Shibata T; Tsurumi Y; Takase S; Okuhara M; Terano H; Kohsaka M; Imanaka H
    J Antibiot (Tokyo); 1992 Mar; 45(3):348-54. PubMed ID: 1374374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of tumor invasion and metastasis by retinoid 4-APR].
    Shi B; Li LM; You SQ; Xu SP; Han R
    Yao Xue Xue Bao; 1997; 32(1):33-7. PubMed ID: 11243215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
    Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.
    Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; De Placido S; Bianco AR; Tortora G
    Clin Cancer Res; 2000 May; 6(5):2053-63. PubMed ID: 10815932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
    Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models.
    Akinaga S; Gomi K; Morimoto M; Tamaoki T; Okabe M
    Cancer Res; 1991 Sep; 51(18):4888-92. PubMed ID: 1893379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cinnamamide, an antitumor agent with low cytotoxicity acting on matrix metalloproteinase.
    Jiang X; Zhen Y
    Anticancer Drugs; 2000 Jan; 11(1):49-54. PubMed ID: 10757563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.
    Kraus-Berthier L; Guilbaud N; Léonce S; Parker T; Genissel P; Guillonneau C; Goldstein S; Atassi G; Pierré A
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):95-103. PubMed ID: 12172972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
    Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
    Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
    Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor and antimetastatic activities of Angelica keiskei roots, part 1: Isolation of an active substance, xanthoangelol.
    Kimura Y; Baba K
    Int J Cancer; 2003 Sep; 106(3):429-37. PubMed ID: 12845685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis.
    Fujita M; Hayashi I; Yamashina S; Itoman M; Majima M
    Biochem Biophys Res Commun; 2002 Jun; 294(2):441-7. PubMed ID: 12051731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.